Answers are grounded in this paper and cite their sources.
Most transcriptomic studies of colorectal neoplasia contrast carcinoma with normal tissue, leaving it uncertain which changes are established in precancerous lesions and reproducible across cohorts. We used a sequential four-dataset framework to identify early-persistent tissue-expression changes while separating discovery from final validation. GSE41657 defined stage-resolved patterns; patient-matched GSE117606 and GSE232110 provided microarray and RNA-sequencing replication; and GSE20916 was reserved for final testing of a procedurally locked candidate list. Fixed rules identified 1407 early-persistent genes, 835 of which replicated in GSE117606 and 617 in GSE232110. Forty-nine candidates were locked before GSE20916 analysis; all retained the expected adenoma direction and candidate-family false discovery rate < 0.05 in the macrodissected primary analysis, and 43 retained support in the source-clustered carcinoma comparison. Results are reported for all 49 candidates and the 39-gene subset. Thirty-six of 49 candidates overlapped a published adenoma signature in the same direction. Marker-score analyses linked the expression signal to mature epithelial differentiation and stromal state. All 49 directions persisted in six tubular RNA-seq pairs, although none met exact-test candidate-family FDR < 0.05; discovery-stage interpretation remained limited by technical and tissue-source confounding. These findings identify recurrent adenoma-associated tissue-expression changes and provide a cross-cohort resource for biological prioritization and targeted follow-up.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: